Results from a CANMAT-led randomized double-blind placebo-controlled trial to determine the optimal length of treatment with atypical antipsychotics, adjunct to mood stabilizers, after remission of a manic episode.
This content is restricted to site members. If you are an existing user, please log in. New users may register below.